pentoxifylline has been researched along with Jaw Diseases in 8 studies
Jaw Diseases: Diseases involving the JAW.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this experimental study was to investigate the prophylactic effect of pentoxifylline (PTX) on medication-related osteonecrosis of the jaw (MRONJ)." | 7.85 | Preventive Effect of Phosphodiesterase Inhibitor Pentoxifylline Against Medication-Related Osteonecrosis of the Jaw: An Animal Study. ( Cumbul, A; Duygu-Capar, G; Sencift, K; Uslu, Ü; Yalcin-Ulker, GM, 2017) |
| "Pentoxifylline has been used to treat complications related to fibrosis for over 20 years." | 6.55 | Pentoxifylline - a review of its use in osteoradionecrosis. ( Brennan, PA; Lyons, AJ, 2017) |
| "To review the conservative and surgical management options of osteoradionecrosis, in particular, highlighting the recent the use of anti-radiation fibrosis drugs (pentoxifylline, tocopherol and clodronate)." | 4.91 | The management of osteoradionecrosis of the jaws--a review. ( Ekanayake, K; Omer, O; Polyzois, I; Rice, N; Stassen, LF, 2015) |
| "The aim of this experimental study was to investigate the prophylactic effect of pentoxifylline (PTX) on medication-related osteonecrosis of the jaw (MRONJ)." | 3.85 | Preventive Effect of Phosphodiesterase Inhibitor Pentoxifylline Against Medication-Related Osteonecrosis of the Jaw: An Animal Study. ( Cumbul, A; Duygu-Capar, G; Sencift, K; Uslu, Ü; Yalcin-Ulker, GM, 2017) |
| "Pentoxifylline has been used to treat complications related to fibrosis for over 20 years." | 2.55 | Pentoxifylline - a review of its use in osteoradionecrosis. ( Brennan, PA; Lyons, AJ, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yalcin-Ulker, GM | 1 |
| Cumbul, A | 1 |
| Duygu-Capar, G | 1 |
| Uslu, Ü | 1 |
| Sencift, K | 1 |
| Kolokythas, A | 1 |
| Rasmussen, JT | 1 |
| Reardon, J | 1 |
| Feng, C | 1 |
| McCaul, JA | 1 |
| Rice, N | 1 |
| Polyzois, I | 1 |
| Ekanayake, K | 1 |
| Omer, O | 1 |
| Stassen, LF | 1 |
| Lyons, AJ | 1 |
| Brennan, PA | 2 |
| Lyons, A | 1 |
| Ghazali, N | 1 |
| Epstein, MS | 1 |
| Wicknick, FW | 1 |
| Epstein, JB | 1 |
| Berenson, JR | 1 |
| Gorsky, M | 1 |
| McLeod, NM | 1 |
| Pratt, CA | 1 |
| Mellor, TK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ): A Prospective, Randomized Controlled Trial to Evaluate a Novel Non-operative Treatment[NCT03040778] | Phase 3 | 100 participants (Anticipated) | Interventional | 2018-04-01 | Enrolling by invitation | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for pentoxifylline and Jaw Diseases
| Article | Year |
|---|---|
Management of osteoradionecrosis of the jaws with pentoxifylline-tocopherol: a systematic review of the literature and meta-analysis.
Topics: Antioxidants; Drug Combinations; Head and Neck Neoplasms; Humans; Jaw Diseases; Osteoradionecrosis; | 2019 |
Pharmacologic modalities in the treatment of osteoradionecrosis of the jaw.
Topics: Anti-Bacterial Agents; Antioxidants; Bone Density Conservation Agents; Chemoradiotherapy; Clodronic | 2014 |
The management of osteoradionecrosis of the jaws--a review.
Topics: Algorithms; Anti-Inflammatory Agents; Clodronic Acid; Fibrosis; Head and Neck Neoplasms; Humans; Hyp | 2015 |
Pentoxifylline - a review of its use in osteoradionecrosis.
Topics: Humans; Jaw Diseases; Osteoradionecrosis; Pentoxifylline | 2017 |
4 other studies available for pentoxifylline and Jaw Diseases
| Article | Year |
|---|---|
Preventive Effect of Phosphodiesterase Inhibitor Pentoxifylline Against Medication-Related Osteonecrosis of the Jaw: An Animal Study.
Topics: Animals; Female; Jaw Diseases; Osteonecrosis; Pentoxifylline; Phosphodiesterase Inhibitors; Rats, Sp | 2017 |
Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment.
Topics: Animals; Antioxidants; Cranial Irradiation; Cytokines; Drug Combinations; Drug Synergism; Fibrosis; | 2008 |
Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series.
Topics: Administration, Oral; Aged; Aged, 80 and over; alpha-Tocopherol; Anti-Infective Agents, Local; Antio | 2010 |
Pentoxifylline and tocopherol in the management of patients with osteoradionecrosis, the Portsmouth experience.
Topics: Aged; Antioxidants; Female; Follow-Up Studies; Humans; Jaw Diseases; Male; Middle Aged; Mouth Neopla | 2012 |